How does DVTC's PB Ratio compare to its peers?

Insufficient data to calculate DVTC's Price-To-Book Ratio vs. peers for valuation analysis.

How does DVTC's PB Ratio compare vs other companies in the US Medical Equipment Industry?

Insufficient data to calculate DVTC's Price-To-Book Ratio vs. industry for valuation analysis.

What is DVTC's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate DVTC's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of DVTC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate DVTC's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

DVTC Stock Overview

Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies. More details

DVTC fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Shares are highly illiquid

Does not have a meaningful market cap ($99M)

My Notes

Capture your thoughts, links and company narrative

Development Technologies Corp. Competitors

FONAR

NasdaqCM:FONR

US$97.5m

Milestone Scientific

NYSEAM:MLSS

US$91.9m

LENSAR

NasdaqCM:LNSR

US$95.8m

Fractyl Health

NasdaqGM:GUTS

US$89.0m

Price History & Performance

Summary of share price highs, lows and changes for Development Technologies
Historical stock prices
Current Share Price	US$9.00
52 Week High	US$9.25
52 Week Low	US$1.02
Beta	0
1 Month Change	-2.70%
3 Month Change	44.00%
1 Year Change	51.52%
3 Year Change	-76.00%
5 Year Change	291.30%
Change since IPO	-99.80%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	DVTC	US Medical Equipment	US Market
7D	-1.3%	1.0%	-2.1%
1Y	51.5%	8.7%	21.3%

Return vs Industry: DVTC exceeded the US Medical Equipment industry which returned 8.7% over the past year.

Return vs Market: DVTC exceeded the US Market which returned 21.3% over the past year.

Price Volatility

Is DVTC's price volatile compared to industry and market?
DVTC volatility
DVTC Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	8.2%
Market Average Movement	6.4%
10% most volatile stocks in US Market	18.9%
10% least volatile stocks in US Market	3.2%

Stable Share Price: DVTC's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine DVTC's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1995	n/a	Daniel Kesonen	www.pegasusbiosciences.com

Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies. The company offers HeartVue 6S System, which is a screening tool used to diagnose heart and other cardiac diseases. It serves cardiologists, general practitioners, physicians, intensive care units, hospitals, emergency rooms, clinics, fitness facilities, sports teams, and other emergency medical facilities.

Development Technologies Corp. Fundamentals Summary

How do Development Technologies's earnings and revenue compare to its market cap?
DVTC fundamental statistics
Market cap	US$99.01m
Earnings (TTM)	US$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is DVTC overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DVTC income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$0
Earnings	US$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did DVTC perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/12 08:16
End of Day Share Price	2025/01/08 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Development Technologies Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution